Skip to main content
Erschienen in: Clinical Reviews in Allergy & Immunology 1/2015

01.02.2015

Definition of Critical Asthma Syndromes

verfasst von: Nicholas Kenyon, Amir A. Zeki, Timothy E. Albertson, Samuel Louie

Erschienen in: Clinical Reviews in Allergy & Immunology | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

Urgent visits to the clinic and emergency department for acute severe asthma exacerbations are all too frequent. Existing national guidelines do not present consistent or specific recommendations for the evaluation and treatment of individual asthma patients in respiratory distress. In this vein, we propose the term "critical asthma syndrome" (CAS) to describe any child or adult who is at high risk for fatal asthma. Acute severe asthma, refractory asthma, status asthmaticus, and near-fatal asthma all describe CAS where physical exhaustion from the overwhelming work of breathing leads to respiratory arrest and death from hypoxia or related complications. The authors of this supplement seek to emphasize the importance of early recognition, prompt and coordinated evaluation, and treatment of CAS in the emergency department, hospital, and intensive care units by experienced healthcare provider teams. CAS is not severe persistent asthma where control of symptoms and prevention of exacerbations are targets of chronic disease management in the outpatient setting. The authors address the distinctions between the two entities throughout the supplement, and elaborate on the considerations important in the care of a critically ill patient, including the common errors to avoid. In addition, gaps in knowledge and clinical experience in regards to critical asthma are highlighted. Knowledge gaps include a lack of understanding of how to recognize CAS, how to coordinate and integrate hospital and outpatient resources, when to further phenotype patients with critical asthma in order to facilitate effective treatment, and how to prevent future acute exacerbations. Lastly, CAS is complicated by the fact that asthma care in diverse healthcare settings is haphazard. We recommend that primary care physicians refer patients promptly to an asthma specialist for consultation to reduce the frequency of acute exacerbations and prevent the development of CAS.
Literatur
1.
Zurück zum Zitat National Asthma Education and Prevention Program (2007) Expert Panel Report 3 (EPR-3): guidelines for the diagnosis and management of asthma-summary report 2007. J Allergy Clin Immunol 120:S94–S138CrossRef National Asthma Education and Prevention Program (2007) Expert Panel Report 3 (EPR-3): guidelines for the diagnosis and management of asthma-summary report 2007. J Allergy Clin Immunol 120:S94–S138CrossRef
2.
Zurück zum Zitat Kroegel C (2009) Global Initiative for Asthma (GINA) guidelines: 15 years of application. Expert Rev Clin Immunol 5:239–249PubMedCrossRef Kroegel C (2009) Global Initiative for Asthma (GINA) guidelines: 15 years of application. Expert Rev Clin Immunol 5:239–249PubMedCrossRef
3.
4.
Zurück zum Zitat Tsai CL, Lee WY, Hanania NA, Camargo CA (2012) Age-related differences in clinical outcomes for acute asthma in the United States, 2006–2008. J Allergy Clin Immunol 129:1252–1258PubMedCrossRef Tsai CL, Lee WY, Hanania NA, Camargo CA (2012) Age-related differences in clinical outcomes for acute asthma in the United States, 2006–2008. J Allergy Clin Immunol 129:1252–1258PubMedCrossRef
5.
Zurück zum Zitat Sly RM (1984) Increases in deaths from asthma. Ann Allergy 53:20–25PubMed Sly RM (1984) Increases in deaths from asthma. Ann Allergy 53:20–25PubMed
6.
Zurück zum Zitat Greiling AK, Boss LP, Wheeler LS (2005) A preliminary investigation of asthma mortality in schools. J Sch Health 75:286–290PubMedCrossRef Greiling AK, Boss LP, Wheeler LS (2005) A preliminary investigation of asthma mortality in schools. J Sch Health 75:286–290PubMedCrossRef
7.
Zurück zum Zitat Moorman JE, Akinbami LJ, Bailey CM et al. (2012) National surveillance of asthma: United States, 2001–2010. DHHS Publincation No. (PHS) 2013–1419. 3:1–67 Moorman JE, Akinbami LJ, Bailey CM et al. (2012) National surveillance of asthma: United States, 2001–2010. DHHS Publincation No. (PHS) 2013–1419. 3:1–67
8.
Zurück zum Zitat Fuhlbrigge AL, Adams RJ, Guilbert TW et al (2002) The burden of asthma in the United States: level and distribution are dependent on interpretation of the national asthma education and prevention program guidelines. Am J Respir Crit Care Med 166:1044–1049PubMedCrossRef Fuhlbrigge AL, Adams RJ, Guilbert TW et al (2002) The burden of asthma in the United States: level and distribution are dependent on interpretation of the national asthma education and prevention program guidelines. Am J Respir Crit Care Med 166:1044–1049PubMedCrossRef
9.
Zurück zum Zitat Peters SP, Jones CA, Haselkorn T, Mink DR, Valacer DJ, Weiss ST (2007) Real-world Evaluation of Asthma Control and Treatment (REACT): findings from a national Web-based survey. J Allergy Clin Immunol 119:1454–1461PubMedCrossRef Peters SP, Jones CA, Haselkorn T, Mink DR, Valacer DJ, Weiss ST (2007) Real-world Evaluation of Asthma Control and Treatment (REACT): findings from a national Web-based survey. J Allergy Clin Immunol 119:1454–1461PubMedCrossRef
10.
Zurück zum Zitat Moore WC, Bleecker ER, Curran-Everett D et al (2007) Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol 119:405–413PubMedCentralPubMedCrossRef Moore WC, Bleecker ER, Curran-Everett D et al (2007) Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol 119:405–413PubMedCentralPubMedCrossRef
11.
Zurück zum Zitat American Thoracic Society (2000) Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. Am J Respir Crit Care Med 162:2341–2351CrossRef American Thoracic Society (2000) Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. Am J Respir Crit Care Med 162:2341–2351CrossRef
12.
Zurück zum Zitat Bush A, Zar HJ (2011) WHO universal definition of severe asthma. Curr Opin Allergy Clin Immunol 11:115–121PubMedCrossRef Bush A, Zar HJ (2011) WHO universal definition of severe asthma. Curr Opin Allergy Clin Immunol 11:115–121PubMedCrossRef
13.
Zurück zum Zitat Busse WW (2011) Asthma diagnosis and treatment: filling in the information gaps. J Allergy Clin Immunol 128:740–750PubMedCrossRef Busse WW (2011) Asthma diagnosis and treatment: filling in the information gaps. J Allergy Clin Immunol 128:740–750PubMedCrossRef
14.
Zurück zum Zitat Wenzel SE, Schwartz LB, Langmack EL et al (1999) Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 160:1001–1008PubMedCrossRef Wenzel SE, Schwartz LB, Langmack EL et al (1999) Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 160:1001–1008PubMedCrossRef
15.
Zurück zum Zitat Woodruff PG, Modrek B, Choy DF et al (2009) T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med 180:388–395PubMedCentralPubMedCrossRef Woodruff PG, Modrek B, Choy DF et al (2009) T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med 180:388–395PubMedCentralPubMedCrossRef
16.
Zurück zum Zitat Amelink M, de Nijs SB, de Groot JC, van Tilburg PM et al (2013) Three phenotypes of adult-onset asthma. Allergy 68:674–680PubMedCrossRef Amelink M, de Nijs SB, de Groot JC, van Tilburg PM et al (2013) Three phenotypes of adult-onset asthma. Allergy 68:674–680PubMedCrossRef
17.
Zurück zum Zitat Kim TB, Jang HS, Kwon JS et al (2013) Identification of asthma clusters in two independent Korean adult asthma cohorts. Eur Respir J 41(6):1308–1314PubMedCrossRef Kim TB, Jang HS, Kwon JS et al (2013) Identification of asthma clusters in two independent Korean adult asthma cohorts. Eur Respir J 41(6):1308–1314PubMedCrossRef
18.
Zurück zum Zitat Fitzpatrick AM, Teague WG, Meyers DA, National Institutes of Health/National Heart, Lung, and Blood Institute Severe Asthma Research Program et al (2011) Heterogeneity of severe asthma in childhood: confirmation by cluster analysis of children in the National Institutes of Health/National Heart, Lung, and Blood Institute Severe Asthma Research Program. J Allergy Clin Immunol 127(2):382–389PubMedCentralPubMedCrossRef Fitzpatrick AM, Teague WG, Meyers DA, National Institutes of Health/National Heart, Lung, and Blood Institute Severe Asthma Research Program et al (2011) Heterogeneity of severe asthma in childhood: confirmation by cluster analysis of children in the National Institutes of Health/National Heart, Lung, and Blood Institute Severe Asthma Research Program. J Allergy Clin Immunol 127(2):382–389PubMedCentralPubMedCrossRef
19.
Zurück zum Zitat Patrawalla PA, Kazeros L, Rogers Y et al (2012) Application of the asthma phenotype algorithm from the Severe Asthma Research Program to an urban population. PLoS One 7(9):e44540PubMedCentralPubMedCrossRef Patrawalla PA, Kazeros L, Rogers Y et al (2012) Application of the asthma phenotype algorithm from the Severe Asthma Research Program to an urban population. PLoS One 7(9):e44540PubMedCentralPubMedCrossRef
20.
Zurück zum Zitat Turner-Warwick M (1971) Provoking factors in asthma. British J Dis Chest 65:1–20CrossRef Turner-Warwick M (1971) Provoking factors in asthma. British J Dis Chest 65:1–20CrossRef
23.
Zurück zum Zitat McKenna JJ, Bramley AM, Skarbinski J, Fry AM, Finelle L, Jain S (2009) Asthma in patients hospitalized with pandemic influenza A(H1N1)pdm09 virus infection-United States, 2009. BMC Infect Dis 13:57. doi:10.1186/1471-2334-13-57 CrossRef McKenna JJ, Bramley AM, Skarbinski J, Fry AM, Finelle L, Jain S (2009) Asthma in patients hospitalized with pandemic influenza A(H1N1)pdm09 virus infection-United States, 2009. BMC Infect Dis 13:57. doi:10.​1186/​1471-2334-13-57 CrossRef
24.
Zurück zum Zitat Mortensen E, Louie J, Pertowski C et al (2013) Epidemiology and outcomes of adults with asthma who were hospitalized or died with 2009 pandemic influenza A (H1N1) — California, 2009. Influenza Other Respir Viruses. doi:10.1111/irv.12120 PubMed Mortensen E, Louie J, Pertowski C et al (2013) Epidemiology and outcomes of adults with asthma who were hospitalized or died with 2009 pandemic influenza A (H1N1) — California, 2009. Influenza Other Respir Viruses. doi:10.​1111/​irv.​12120 PubMed
25.
Zurück zum Zitat Jeffery PK (2001) Remodeling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med 164:S28–S38PubMedCrossRef Jeffery PK (2001) Remodeling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med 164:S28–S38PubMedCrossRef
26.
Zurück zum Zitat Mauadk T, Bel EH, Sterk PJ (2007) Asthma therapy and airway remodeling. J Allergy Clin Immunol 120:997–1009CrossRef Mauadk T, Bel EH, Sterk PJ (2007) Asthma therapy and airway remodeling. J Allergy Clin Immunol 120:997–1009CrossRef
27.
Zurück zum Zitat Brewster CE, Howarth PH, Djukanovic R, Wilson J, Holgate ST, Roche RW (1990) Myofibroblasts and subepithelial fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 3:507–511PubMedCrossRef Brewster CE, Howarth PH, Djukanovic R, Wilson J, Holgate ST, Roche RW (1990) Myofibroblasts and subepithelial fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 3:507–511PubMedCrossRef
28.
Zurück zum Zitat Martin RJ, Szefler SJ, King TS et al (2007) The Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) trial. J Allergy Clin Immunol 119:73–80PubMedCentralPubMedCrossRef Martin RJ, Szefler SJ, King TS et al (2007) The Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) trial. J Allergy Clin Immunol 119:73–80PubMedCentralPubMedCrossRef
Metadaten
Titel
Definition of Critical Asthma Syndromes
verfasst von
Nicholas Kenyon
Amir A. Zeki
Timothy E. Albertson
Samuel Louie
Publikationsdatum
01.02.2015
Verlag
Springer US
Erschienen in
Clinical Reviews in Allergy & Immunology / Ausgabe 1/2015
Print ISSN: 1080-0549
Elektronische ISSN: 1559-0267
DOI
https://doi.org/10.1007/s12016-013-8395-6

Weitere Artikel der Ausgabe 1/2015

Clinical Reviews in Allergy & Immunology 1/2015 Zur Ausgabe

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

HNO-Op. auch mit über 90?

16.04.2024 HNO-Chirurgie Nachrichten

Mit Blick auf das Risiko für Komplikationen nach elektiven Eingriffen im HNO-Bereich scheint das Alter der Patienten kein ausschlaggebender Faktor zu sein. Entscheidend ist offenbar, wie fit die Betroffenen tatsächlich sind.

Intrakapsuläre Tonsillektomie gewinnt an Boden

16.04.2024 Tonsillektomie Nachrichten

Gegenüber der vollständigen Entfernung der Gaumenmandeln hat die intrakapsuläre Tonsillektomie einige Vorteile, wie HNO-Fachleute aus den USA hervorheben. Sie haben die aktuelle Literatur zu dem Verfahren gesichtet.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.